{"title_page": "4-Benzylpiperidine", "text_new": "{{Drugbox\n| Verifiedfields = changed\n| verifiedrevid = 477221136\n| drug_name = \n| type = \n| IUPAC_name = 4-(phenylmethyl)piperidine\n| image = 4-Benzylpiperidine.png\n| alt = \n| caption = \n| image2 = 4-benzylpiperidine.png\n\n<!--Clinical data-->| tradename = \n| MedlinePlus = \n| licence_EU = \n| licence_US = \n| pregnancy_AU = \n| pregnancy_US = \n| pregnancy_category = \n| legal_DE = The NpSG do not apply to this substance, because it is not a 2-Phenylethylamine derivative\n| legal_UK = PSA\n| legal_status = \n| routes_of_administration = <!--Pharmacokinetic data-->\n| bioavailability = \n| metabolism = \n| elimination_half-life = \n| excretion = <!--Identifiers-->\n| CAS_number_Ref = {{cascite|changed|??}}\n| CAS_number = 31252-42-3\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = JDF1T4667S\n| ATC_suffix = \n| PubChem = 31738\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| DrugBank = \n| ChemSpiderID = 29432\n| ChEMBL_Ref = {{ebicite|correct|EBI}}\n| ChEMBL = 144129\n\n<!--Chemical data-->| C = 12\n| H = 17\n| N = 1\n| molecular_weight = 175.270 g/mol\n| smiles = C1CNCCC1CC2=CC=CC=C2\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C12H17N/c1-2-4-11(5-3-1)10-12-6-8-13-9-7-12/h1-5,12-13H,6-10H2\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = ABGXADJDTPFFSZ-UHFFFAOYSA-N\n}}\n\n'''4-Benzylpiperidine''' is a [[drug]] and research chemical used in scientific studies. It acts as a [[monoamine]] [[releasing agent]] with 20- to 48-fold selectivity for releasing [[dopamine]] versus [[serotonin]]. It is most efficacious as a releaser of norepinephrine, with an ec50 of 109/41.4/5246nM for DA/NE/5HT, respectively .<ref name=\"pmid19151247\">{{cite journal |vauthors=Negus SS, Baumann MH, Rothman RB, Mello NK, Blough BE | title = Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. | journal = J Pharmacol Exp Ther | volume = 329 | issue = 1 | pages = 272\u2013281 | year = 2009 | pmid = 19151247 | doi = 10.1124/jpet.108.143701 | pmc = 2670586 }}</ref> It has a fast onset of action and a short duration.<ref name=\"pmid19151247\" /> It also functions as a [[monoamine oxidase]] [[monoamine oxidase inhibitor|inhibitor]] (MAOI) with preference for [[monoamine oxidase A|MAO-A]].<ref name=\"pmid3490636\">{{cite journal |vauthors=Arai Y, Hamamichi N, Kinemuchi H | title = Time-dependent inhibition of rat brain monoamine oxidase by an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine. | journal = Neurosci. Lett. | volume = 70 | issue = 2 | pages = 255\u2013260 | year = 1986 | pmid = 3490636 | doi = 10.1016/0304-3940(86)90473-8 }}</ref> \n\n<br />\n\n==Synthesis==\n[[4-Cyanopyridine]] can be reacted with toluene to give 4-benzylpyridine.<ref name=\"HoshikawaInoue2013\">{{cite journal|last1=Hoshikawa|first1=Tamaki|last2=Inoue|first2=Masayuki|title=Photoinduced direct 4-pyridination of C(sp3)\u2013H Bonds|journal=Chemical Science|volume=4|issue=8|year=2013|pages=3118|issn=2041-6520|doi=10.1039/c3sc51080h}}</ref> [[Catalytic hydrogenation]] of the pyridine ring then completes the synthesis.{{citation needed|date=November 2018}} \n\n==Derivatives==\n#[[Pimetine]], a [[hypolipidemic agent]].\n#[[Benrixate]], an [[antiarrhythmic agent]].\n#[[Ifenprodil]] & Ro-25-6981 (MI-4)\n#TCS 46b\n#ASS234 \n#[[JTV-519]]\n#[[JX-401]]\n#[[KW 4099]] [141364-05-8]\n\n== See also ==\n* [[2-Benzylpiperidine]]\n* [[Benzylpiperazine]]\n\n== References ==\n{{Reflist|2}}\n\n{{Stimulants}}\n{{Monoamine releasing agents}}\n\n{{DEFAULTSORT:Benzylpiperidine, 4-}}\n[[Category:Stimulants]]\n[[Category:Piperidines]]\n[[Category:Designer drugs]]\n[[Category:Norepinephrine-dopamine releasing agents]]\n\n\n{{nervous-system-drug-stub}}\n", "text_old": "{{Drugbox\n| Verifiedfields = changed\n| verifiedrevid = 477221136\n| drug_name = \n| type = \n| IUPAC_name = 4-(phenylmethyl)piperidine\n| image = 4-Benzylpiperidine.png\n| alt = \n| caption = \n| image2 = 4-benzylpiperidine.png\n\n<!--Clinical data-->| tradename = \n| MedlinePlus = \n| licence_EU = \n| licence_US = \n| pregnancy_AU = \n| pregnancy_US = \n| pregnancy_category = \n| legal_DE = The NpSG do not apply to this substance, because it is not a 2-Phenylethylamine derivative\n| legal_UK = PSA\n| legal_status = \n| routes_of_administration = <!--Pharmacokinetic data-->\n| bioavailability = \n| metabolism = \n| elimination_half-life = \n| excretion = <!--Identifiers-->\n| CAS_number_Ref = {{cascite|changed|??}}\n| CAS_number = 31252-42-3\n| ATC_suffix = \n| PubChem = 31738\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| DrugBank = \n| ChemSpiderID = 29432\n| ChEMBL_Ref = {{ebicite|correct|EBI}}\n| ChEMBL = 144129\n\n<!--Chemical data-->| C = 12\n| H = 17\n| N = 1\n| molecular_weight = 175.270 g/mol\n| smiles = C1CNCCC1CC2=CC=CC=C2\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C12H17N/c1-2-4-11(5-3-1)10-12-6-8-13-9-7-12/h1-5,12-13H,6-10H2\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = ABGXADJDTPFFSZ-UHFFFAOYSA-N\n}}\n\n'''4-Benzylpiperidine''' is a [[drug]] and research chemical used in scientific studies. It acts as a [[monoamine]] [[releasing agent]] with 20- to 48-fold selectivity for releasing [[dopamine]] versus [[serotonin]]. It is most efficacious as a releaser of norepinephrine, with an ec50 of 109/41.4/5246nM for DA/NE/5HT, respectively .<ref name=\"pmid19151247\">{{cite journal |vauthors=Negus SS, Baumann MH, Rothman RB, Mello NK, Blough BE | title = Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. | journal = J Pharmacol Exp Ther | volume = 329 | issue = 1 | pages = 272\u2013281 | year = 2009 | pmid = 19151247 | doi = 10.1124/jpet.108.143701 | pmc = 2670586 }}</ref> It has a fast onset of action and a short duration.<ref name=\"pmid19151247\" /> It also functions as a [[monoamine oxidase]] [[monoamine oxidase inhibitor|inhibitor]] (MAOI) with preference for [[monoamine oxidase A|MAO-A]].<ref name=\"pmid3490636\">{{cite journal |vauthors=Arai Y, Hamamichi N, Kinemuchi H | title = Time-dependent inhibition of rat brain monoamine oxidase by an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine. | journal = Neurosci. Lett. | volume = 70 | issue = 2 | pages = 255\u2013260 | year = 1986 | pmid = 3490636 | doi = 10.1016/0304-3940(86)90473-8 }}</ref> \n\n<br />\n\n==Synthesis==\n[[4-Cyanopyridine]] can be reacted with toluene to give 4-benzylpyridine.<ref name=\"HoshikawaInoue2013\">{{cite journal|last1=Hoshikawa|first1=Tamaki|last2=Inoue|first2=Masayuki|title=Photoinduced direct 4-pyridination of C(sp3)\u2013H Bonds|journal=Chemical Science|volume=4|issue=8|year=2013|pages=3118|issn=2041-6520|doi=10.1039/c3sc51080h}}</ref> [[Catalytic hydrogenation]] of the pyridine ring then completes the synthesis.{{citation needed|date=November 2018}} \n\n==Derivatives==\n#[[Pimetine]], a [[hypolipidemic agent]].\n#[[Benrixate]], an [[antiarrhythmic agent]].\n#[[Ifenprodil]] & Ro-25-6981 (MI-4)\n#TCS 46b\n#ASS234 \n#[[JTV-519]]\n#[[JX-401]]\n#[[KW 4099]] [141364-05-8]\n\n== See also ==\n* [[2-Benzylpiperidine]]\n* [[Benzylpiperazine]]\n\n== References ==\n{{Reflist|2}}\n\n{{Stimulants}}\n{{Monoamine releasing agents}}\n\n{{DEFAULTSORT:Benzylpiperidine, 4-}}\n[[Category:Stimulants]]\n[[Category:Piperidines]]\n[[Category:Designer drugs]]\n[[Category:Norepinephrine-dopamine releasing agents]]\n\n\n{{nervous-system-drug-stub}}\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/4-Benzylpiperidine"}
